Ankur Gupta, Yash Pal Sharma. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Adrenergic beta-Antagonists/therapeutic useAngiotensin Receptor Antagonists/therapeutic useAngiotensin-Converting Enzyme Inhibitors/therapeutic useBenzazepines/therapeutic useCardiovascular Agents/therapeutic useChronic DiseaseHeart Failure/drug therapyHeart Failure/physiopathologyHeart Rate/drug effectsHumansIvabradineMineralocorticoid Receptor Antagonists/therapeutic useRandomized Controlled Trials as TopicTreatment Outcome
Substances： See more » Adrenergic beta-AntagonistsAngiotensin Receptor AntagonistsAngiotensin-Converting Enzyme InhibitorsBenzazepinesCardiovascular AgentsMineralocorticoid Receptor AntagonistsIvabradine
Year: 2010 PMID： 21168044 DOI： 10.1016/S0140-6736(10)62285-4
Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321